Skip to main content
Clinical Trials/NL-OMON21327
NL-OMON21327
Not yet recruiting
Not Applicable

Cardiovascular Magnetic resonance imaging and Echocardiography in Rheumatoid Arthritis - Patterns of cardiovascular dysfunction in patients with rheumatoid arthritis.

Medisch Spectrum Twente, Enschede, The NetherlandsDepartment of Cardiology and Department of Rheumatology0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
- cardiovascular disease - rheumatoid arthritis - cardiac magnetic resonance imaging - echocardiography - cardiovasculaire ziekte - reumatoide artritis - cardiale MRI - echocardiografie
Sponsor
Medisch Spectrum Twente, Enschede, The NetherlandsDepartment of Cardiology and Department of Rheumatology
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Medisch Spectrum Twente, Enschede, The NetherlandsDepartment of Cardiology and Department of Rheumatology

Eligibility Criteria

Inclusion Criteria

  • Participants in this study will be selected from a large database of RA patients at the rheumatology department. Three groups of patients with rheumafactor positive and anti\-CCP positive rheumatoid arthritis will be selected. The first group consists of 30 patients with new onset rheumatoid arthritis (early RA group, \< 1 year disease duration). The second group consists of 20 patients with intermediate duration of rheumatoid arthritis (intermediate RA, 5\-10 years disease duration, erosive disease, expert based stable low disease activity \> 6 months). The third group consists of 30 patients with longstanding rheumatoid arthritis (longstanding RA, \> 15 years disease duration, erosive disease, expert based stable low disease activity \> 6 months). The age of the study population is 18\-75 year

Exclusion Criteria

  • previous CV disease, current smoking, age \< 18 or \> 75 years, pregnancy, history of kidney dysfunction (GFR \< 60 ml/min), hypercholesterolemia/dyslipidemia (total cholesterol \> 6\.5 mmol/l), history of hypertension (systolic pressure \> 140 mmHg, diastolic pressure \> 90 mmHg) or use of antihypertensive medication, history of diabetes mellitus (fasting glucose level \> 7\.0 mmol/l), body mass index \> 30 kg/m2, claustrophobia or other exclusion criteria for MRI such as implanted metal materials.

Outcomes

Primary Outcomes

Not specified

Similar Trials